Effect of ketorolac 0.5% drops on patients' pain perception during intravitreal injection procedure.

Purpose: To evaluate the analgesic effect of ketorolac 0.5% drops during the intravitreal injection procedure.

Methods: Thirty patients (n=30) received topical ketorolac 0.

Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse.

We report the clinical course of a 56-year-old patient diagnosed with toxic keratopathy due to topical anesthetic abuse. One month later, while a large corneal epithelial defect persisted, the cornea developed circumferential neovascularization that was treated with subconjunctival bevacizumab. Corneal neovascularization (CN) showed a dramatic regression 1 week after subconjunctival injection of bevacizumab.